Argentus Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Argentus Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,934	Closed	-$283K	–	203
2016 Q3	$283K	Buy	2,934 +1,728	+143%	+$164K	0.1%	264
2016 Q2	$103K	Sell	1,206 -5,478	-82%	-$492K	0.04%	386
2016 Q1	$581K	Buy	6,684 +6,426	+2,491%	+$575K	0.21%	139
2015 Q4	$29K	Sell	258 -1,101	-81%	-$119K	0.01%	432
2015 Q3	$137K	Buy	+1,359	New	+$163K	0.02%	424

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Argentus Capital Management's IBB Position: Q4 2016 in Review

Argentus Capital Management sold out of iShares Biotechnology ETF (IBB) in Q4 2016, closing a stake of 2,934 shares — an estimated $283K sold.

Argentus Capital Management first reported a position in IBB in Q3 2015 and held it in 5 quarters. The position peaked at $581K in Q1 2016. 522 funds tracked by Wall St. Rank hold IBB as of Q4 2016.

Argentus Capital Management reported no remaining iShares Biotechnology ETF position as of Q4 2016 after selling out during the quarter.
Argentus Capital Management sold 2,934 iShares Biotechnology ETF shares in Q4 2016, an estimated $283K.
Argentus Capital Management first reported a position in iShares Biotechnology ETF in Q3 2015 and held it in 5 quarters.
Argentus Capital Management's iShares Biotechnology ETF position peaked at $581K in Q1 2016.
522 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2016.

Based on Argentus Capital Management's 13F filing for Q4 2016.